From paper to the cloud

The author also describes the benefits of a cloud platform in terms of the exchange between different research and development teams.
The development of an approved gene therapy focuses on adeno-associated virus (AAV)-based gene therapies for the treatment of patients affected by haemophilia, Huntington's disease and other severe genetic disorders. A modular and validated cloud platform is used for this purpose. But before moving to a cloud-based platform, paper-based workflows make it difficult to track test results and collaborate across teams and sites. This is the case for many life science companies, as digitalization is not progressing very quickly, especially in research and development (R&D) departments. Read more here the article.